A comparative study of recurrence rate and complications between mitomycin c, interferone alpha 2b and bevasizumab after primary pterygium surgery

Phase 2

Recruiting

• Conditions: Primary pterygium.; Pterygium of eye; H11.0

• Registration Number: IRCT20220215054028N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

Existence of primary pterygium at least 1 mm in size
Decrease in visual acuity due to pterygium
The patient's tendency for pterygium surgery
Having no history of previous pterygium surgery
Having no history of allergy to interferone alpha 2 B
Cylinder caused by pterygium

Exclusion Criteria

Patients with recurrent pterygium
Patients with no tendency for pterygium surgery
Patients with active ophthalmic infection

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pterygium recurrence rate after primary pterygium surgery. Timepoint: At the beginning of the study, after 48 hours, one week, one month, 6 months and then 1 year after the operation. Method of measurement: Slit lamp.;Complication rate after primary pterygium surgery. Timepoint: At the beginning of the study, after 48 hours, one week, one month, 6 months and then 1 year after the operation. Method of measurement: Slit lamp.